Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Rankning i aktier #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$1.17K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel PhaseRx, Inc. (PZRXQ)

Kategori

Aktiekurshistorik för PhaseRx, Inc. (PZRXQ)
Högsta slutkurs: $0.00 den 2026-08-01

Lägsta slutkurs: $5.21 den 2016-05-01
Aktiekurshistorik för PhaseRx, Inc. från 2016 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 -52.25%
2024 0.00%
2023 100.00%
2022 -4.35%
2021 -96.33%
2020 62.38%
2019 -37.88%
2018 -99.53%
2017 -62.39%
2016 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR